Trial Profile
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 in Patients With Seasonal Allergic Rhinitis.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Oct 2011
Price :
$35
*
At a glance
- Drugs Azelastine (Primary)
- Indications Seasonal allergic rhinitis
- Focus Therapeutic Use
- 10 Jun 2011 New trial record